Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/29/c6/bd/29c6bd7c-6b06-9cdd-826c-3cfb9cdeadd0/mza_1862833616945883600.jpg/600x600bb.jpg
NeuroFrontiers
Practical Neurology
11 episodes
1 week ago
Practical Neurology partners with ReachMD to bring you clinical research and advancements that further clinicians' ability to diagnose and treat neurologic conditions. 
Show more...
Life Sciences
Science
RSS
All content for NeuroFrontiers is the property of Practical Neurology and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Practical Neurology partners with ReachMD to bring you clinical research and advancements that further clinicians' ability to diagnose and treat neurologic conditions. 
Show more...
Life Sciences
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/29/c6/bd/29c6bd7c-6b06-9cdd-826c-3cfb9cdeadd0/mza_1862833616945883600.jpg/600x600bb.jpg
Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome
NeuroFrontiers
18 minutes
9 months ago
Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome
Joseph Sullivan, MD, Professor, UCSF School of Medicine, San Francisco, CA, describes encouraging results from the SWALLOWTAIL and LONGWING studies of an investigational treatment for individuals with Dravet syndrome, including outcomes related to seizure frequency, cognition, and behavior.
NeuroFrontiers
Practical Neurology partners with ReachMD to bring you clinical research and advancements that further clinicians' ability to diagnose and treat neurologic conditions.